Atypical meningioma: Randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy

Hannah Yoon, Minesh P. Mehta, Karthikeyan Perumal, Irene B. Helenowski, Richard J. Chappell, Erinc Akture, Yunzhi Lin, Mary Anne H. Marymont, Samir Sejpal, Andrew Parsa, James Chandler, Bernard R. Bendok, Joshua Rosenow, Shahriar Salamat, Priya Kumthekar, Jeffrey Raizer, Mustafa K. Baskaya*

*Corresponding author for this work

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Background: The role of postoperative radiation (RT) in atypical meningioma remains controversial. Materials and Methods: We report a retrospective review of outcomes and prognostic factor analysis in 158 patients treated between 2000 and 2010, and extensively review the literature. Results: Following resection, 23 patients received immediate RT, whereas 135 did not. Median progression-free survival (PFS) with and without RT was 59 (range 43-86) and 88 (range 64-123) months. For Simpson grade (G) 1-3 resection, with and without RT, median PFS was 48 (2-80) versus 96 (88-123) months and for Simpson G4, it was 59 (6-86) versus 47 (15-104) months (P = 0.4). The rate of 5-year overall survival (OS) with and without RT was 89% and 83%, respectively. On univariate analysis, Simpson G4 (HR 3.2, P = 0.0006) and brain invasion (HR 2.2, P = 0.03) were significantly associated with progression, whereas age >60 years (HR 9.7, P = 0.002), mitoses >5 per 10 high-power field (0.2, P = 0.0056), and Simpson G4 (HR 2.4, P = 0.07) were associated with higher risk of death. We summarized 22 additional reports, which provide very divergent results regarding the benefit of RT. Conclusions: In our series, adjuvant RT is surprisingly associated with worse PFS and OS, and this is more likely to be due to selection bias of referring tumors with more aggressive characteristics such as elevated Ki-67 and brain invasion for adjuvant RT, rather than a direct causal effect of adjuvant RT. Although there is a trend toward improved PFS with adjuvant RT after subtotal resection, no improvement was noted in OS. Multivariate analysis did not yield statistical significance for any of the factors including Simpson grades of resection, adjuvant RT, or six pathological defining features. The relatively divergent results in the literature are most likely explained by patient selection variability; therefore, randomized trials to adequately address this question are clearly necessary.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalJournal of Cancer Research and Therapeutics
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015

    Fingerprint

Keywords

  • Atypical meningioma
  • Grade 2 meningioma
  • adjuvant radiotherapy
  • post-operative radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Yoon, H., Mehta, M. P., Perumal, K., Helenowski, I. B., Chappell, R. J., Akture, E., Lin, Y., Marymont, M. A. H., Sejpal, S., Parsa, A., Chandler, J., Bendok, B. R., Rosenow, J., Salamat, S., Kumthekar, P., Raizer, J., & Baskaya, M. K. (2015). Atypical meningioma: Randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. Journal of Cancer Research and Therapeutics, 11(1), 59-66. https://doi.org/10.4103/0973-1482.148708